Notice Filed with SOS |
02/28/2023 |
Rule |
ProposedRuleAttach2023-00143.doc
|
Statutory Authority |
§§ 10-16-156(10), 10-16-109, and 10-1-109, C.R.S. |
Description of Subjects/Issues |
The purpose of this regulation is to establish the reporting requirements for health insurers to demonstrate that all prescription drug rebates and discounts received are used to reduce costs for policyholders in compliance with § 10-16-156, C.R.S. |
Purpose/Objective of Rule |
The purpose of this regulation is to establish the reporting requirements for health insurers to demonstrate that all prescription drug rebates and discounts received are used to reduce costs for policyholders in compliance with Section 10-16-156, C.R.S. |
Submitted in response to issues raised by COLS/OLLS? |
No
|
Is this rule adopted in response to recent legislation? |
No
|
Hearing Date |
03/30/2023 |
Hearing Time |
11:00 AM |
Hearing Location |
Webinar or 1560 Broadway, STE 850, Denver CO 80202 |
Contact Name |
Jill Mullen |
Contact Title |
Policy Advisor |
Contact Telephone |
7205564952 |
Contact email |
jill.mullen@state.co.us |